Paul Schellhammer, M.D.
Professor, Department of Urology, Eastern Virginia Medical School
Dr. Paul Schellhammer received his undergraduate education at the University of Notre Dame and his medical school training at Cornell Medical College in New York City. He received his M.D. degree in 1966. His surgical and urologic training were taken at the University Hospital of Cleveland in Cleveland, Ohio and the Medical College of Virginia, Richmond, Virginia. This was followed by a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. He joined the practice of Devine Poutasse Fiveash Urology in 1974 as a faculty member of Eastern Virginia Medical School. He achieved the rank of Professor at Eastern Virginia Medical School where he also served as Chairman of the Department of Urology and Program Director of the Resident Training Program.
Dr. Schellhammer has published extensively in the field of urologic oncology, specifically prostate cancer, serves on several editorial boards, and has served as a trustee in the American Board of Urology as its President. He has also served as President of the Society of Urologic Oncology, President of his Mid-Atlantic Section of the American Urologic Association, as a member of the Board of Directors of the American Urologic Association, and has been elected President of the American Urologic Association in the year 2007.
Laurence Klotz, M.D.
Chief of Urology; Sunnybrook Health Sciences Centre, Toronto; Chairman, Canadian Urology Research Consortium; Professor of Surgery, University of Toronto.
Dr. Laurence Klotz received his medical degree from the University of Toronto in 1977. His urologic training was taken at Mt Sinai Hospital in Toronto, Ontario, and residency at University of Toronto. This was followed by a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. He is certified with the American Board of Urology.
Dr. Klotz joined the staff of Sunnybrook Health Science Centre, Division of Urology, in Toronto, Ontario in 1985. At that time he also joined as consulting staff at Toronto Bayview Regional Cancer Centre in Toronto. Since 1993, Dr. Klotz as served as research director for the Division of Surgical Oncology at the Toronto Bayview Regional Cancer Centre. He is an associate member at the Institute of Medical Science Graduate Faculty and Professor for the Department of Surgery at the University of Toronto.
Howard Sandler, M.D.
Professor and Senior Associate Chair, Department of Radiation Oncology; Professor, Department of Urology, University of Michigan.
Dr. Howard Sandler received his medical degree from the University of Connecticut in 1985 and completed his residency in Radition Oncology at Hospital of the University of Pennsylvania. He is a board-certified Radition Oncologist and is current Professor and Senior Associate Chair of the Department of Radiation Oncology and Professor of Urology at the University of Michigan Medical School.
Dr. Sandler is the principal investigator of the national Radiation Therapy Oncology Group (RTOG) protocol studying radiotherapy and chemotherapy for prostate cancer and is the principal investigator of an NIH-funded clinical trial grant investigating aspects of prostate cancer irradiation. He is also the chair of the Genitourinary Cancer Committee of the RTOG. Dr. Sandler is an active clinical trial scientist and has used an extensive prostate cancer database to study the role of radiation therapy in the treatment of prostate cancer.
Oliver Sartor, M.D.
Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School.
Dr. Oliver Sartor received his MD degree in 1982 from Tulane University School of Medicine. He initially began to focus on prostate cancer when he was hired as a senior investigator at the National Cancer Institute in 1990. During the following three years, Dr. Sartor worked at the National Cancer Institute under the direction of Dr. Charles Myers in the advanced prostate cancer clinics at the National Institute of Health. During this time a variety of experimental therapies were examined and an increased understanding of advanced prostate cancer resulted from these studies.
In 1998 Dr. Sartor became Chief of the section of Hematology/Oncology and Director at the Stanley S. Scott Cancer Center at LSU Health Sciences Center in New Orleans. During that period of time he continued to develop his academic prostate cancer practice as well as build an increasingly competitive academic cancer center in New Orleans. Following Hurricane Katrina, in the Spring of 2006, Dr. Sartor moved to Boston and joined the Medical Oncology team in the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute/Harvard Medical School.
 |
Jointly sponsored through the American Academy of CME and NAME, North American Medical Education group.
This activity is supported by an educational grant from AstraZeneca.